.png)
Weight loss injections like Ozempic® and Wegovy® have become popular — but serious concerns are emerging. One of the most alarming potential side effects of semaglutide is vision loss. For bariatric patients, understanding the eye risks of semaglutide is critical when choosing a safe, effective weight loss method.
At BASS Bariatric Surgery Center, we focus only on surgical weight loss solutions because they offer long-term safety and results — without relying on medications that may carry unknown risks.
Semaglutide is a medication originally developed for managing Type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists and is now prescribed for weight loss under brand names like:
These drugs help reduce appetite and improve blood sugar control. But for bariatric patients — especially those without diabetes — the long-term effects are still unclear.
Recent reports suggest a possible link between semaglutide and a rare but serious condition called nonarteritic anterior ischemic optic neuropathy (NAION). This condition causes sudden and permanent vision loss due to decreased blood flow to the optic nerve.
While the data is still emerging, potential risks include:
Semaglutide eye risks may be higher in individuals with:
Our bariatric surgeons focus on evidence-based surgical care, not medications like semaglutide or tirzepatide. Here’s why:
In contrast, bariatric surgeries like gastric bypass and sleeve gastrectomy:
If you're using a weight loss injection and experiencing vision issues or other side effects, talk to your doctor right away.
Better yet — consider a permanent and safer alternative.
At BASS Bariatric Surgery Center, we help patients reach their health goals through time-tested surgical procedures. We do not prescribe semaglutide or other GLP-1 medications because we believe in sustainable, comprehensive care.
Want to learn more about weight loss surgery options?